354 related articles for article (PubMed ID: 23360674)
1. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer.
van Dorp W; van den Heuvel-Eibrink MM; de Vries AC; Pluijm SM; Visser JA; Pieters R; Laven JS
Hum Reprod; 2014 Feb; 29(2):337-42. PubMed ID: 24345579
[TBL] [Abstract][Full Text] [Related]
3. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
6. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi ALF; van Dijk M; Broer L; van den Berg MH; Laven JSE; van Leeuwen FE; Lambalk CB; Overbeek A; Loonen JJ; van der Pal HJ; Tissing WJ; Versluys B; Bresters D; Beerendonk CCM; Ronckers CR; van der Heiden-van der Loo M; Kaspers GL; de Vries ACH; Robison LL; Hudson MM; Chemaitilly W; Byrne J; Berger C; Clemens E; Dirksen U; Winther JF; Fosså SD; Grabow D; Haupt R; Kaiser M; Kepak T; Kruseova J; Modan-Moses D; Pluijm SMF; Spix C; Zolk O; Kaatsch P; Krijthe JH; Kremer LC; Yasui Y; Brooke RJ; Uitterlinden AG; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E
Hum Reprod; 2021 Mar; 36(4):1120-1133. PubMed ID: 33582778
[TBL] [Abstract][Full Text] [Related]
7. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
[TBL] [Abstract][Full Text] [Related]
8. Shared genetic factors for age at natural menopause in Iranian and European women.
Rahmani M; Earp MA; Ramezani Tehrani F; Ataee M; Wu J; Treml M; Nudischer R; P-Behnami S; ; Perry JR; Murabito JM; Azizi F; Brooks-Wilson A
Hum Reprod; 2013 Jul; 28(7):1987-94. PubMed ID: 23592221
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.
Uncu G; Kasapoglu I; Ozerkan K; Seyhan A; Oral Yilmaztepe A; Ata B
Hum Reprod; 2013 Aug; 28(8):2140-5. PubMed ID: 23624580
[TBL] [Abstract][Full Text] [Related]
10. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
[TBL] [Abstract][Full Text] [Related]
11. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
[TBL] [Abstract][Full Text] [Related]
13. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
[TBL] [Abstract][Full Text] [Related]
14. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study.
Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT
Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477
[TBL] [Abstract][Full Text] [Related]
15. Hypoandrogenism in association with diminished functional ovarian reserve.
Gleicher N; Kim A; Weghofer A; Kushnir VA; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
Hum Reprod; 2013 Apr; 28(4):1084-91. PubMed ID: 23427231
[TBL] [Abstract][Full Text] [Related]
16. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ
Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability.
Rustamov O; Smith A; Roberts SA; Yates AP; Fitzgerald C; Krishnan M; Nardo LG; Pemberton PW
Hum Reprod; 2012 Oct; 27(10):3085-91. PubMed ID: 22777530
[TBL] [Abstract][Full Text] [Related]
18. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
19. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
20. Excess mortality in mothers of patients with polycystic ovary syndrome.
Louwers YV; Roest-Schalken ME; Kleefstra N; Roeters van Lennep J; van den Berg M; Fauser BC; Bilo HJ; Sijbrands EJ; Laven JS
Hum Reprod; 2014 Aug; 29(8):1780-6. PubMed ID: 24876175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]